Go to Header
Go to Navigation
Go to Content
Go to Footer
Login
Help
中文（繁體）
Research Resources
CUHK UPDates
Theses
Experts List
User Guides
About Us
List of Researchers
> Professor Nathalie WONG
Home
Research Outputs
Researcher Profiles
Department Profiles
Research Areas
Professor Nathalie WONG
Personal Information
Position and Department
Professor
,
Department of Surgery
ORCiD
0000-0003-2397-9189
CUHK Research Outputs
1 of 5
VSTM2A reverses immunosuppression in colorectal cancer by antagonizing the PD-L1/PD-1 interaction
(
2024
)
Bifidobacterium pseudolongum-generated acetate suppresses non-alcoholic fatty liver disease-associated hepatocellular carcinoma
(
2023
)
Long-read sequencing identified novel citrate synthase variant contributing to metastatic phenotype through metabolic alterations in colorectal carcinoma
(
2023
)
Mechanical manipulation of cancer cell tumorigenicity via heat shock protein signaling
(
2023
)
METTL3 drives NAFLD-related hepatocellular carcinoma and is a therapeutic target for boosting immunotherapy
(
2023
)
Novel exon-skipping citrate synthase isoform identified in hybrid sequencing contributes to metastatic phenotype in colorectal cancer through metabolic alterations
(
2023
)
The molecular classification of cancer-associated fibroblasts on a pan-cancer single-cell transcriptional atlas
(
2023
)
T lymphocytes expressing the switchable chimeric Fc receptor CD64 exhibit augmented persistence and antitumor activity
(
2023
)
TP53 R249S mutation in hepatic organoids captures the predisposing cancer risk
(
2023
)
VSTM2A modulation of immune response in colorectal cancer through abrogating PD-L1 and PD-1 interaction
(
2023
)
Control of SARS-CoV-2 infection by MT1-MMP-mediated shedding of ACE2
(
2022
)
Development of CD44E/s dual-targeting DNA aptamer as nanoprobe to deliver treatment in hepatocellular carcinoma
(
2022
)
Identification of Tissue Types and Gene Mutations From Histopathology Images for Advancing Colorectal Cancer Biology
(
2022
)
More than a duologue: In-depth insights into epitranscriptomics and ferroptosis
(
2022
)
Overexpression of nucleotide metabolic enzyme DUT in hepatocellular carcinoma potentiates a therapeutic opportunity through targeting its dUTPase activity
(
2022
)
Personalized treatment for hepatocellular carcinoma: Current status and future perspectives
(
2022
)
Unique molecular characteristics of NAFLD-associated liver cancer accentuate β-catenin/TNFRSF19-mediated immune evasion
(
2022
)
Establishment and characterization of meningioma patient-derived organoid
(
2021
)
Manipulation of the Nanoscale Presentation of Integrin Ligand Produces Cancer Cells with Enhanced Stemness and Robust Tumorigenicity
(
2021
)
NOTCH3, a crucial target of miR-491-5p/miR-875-5p, promotes gastric carcinogenesis by upregulating PHLDB2 expression and activating Akt pathway
(
2021
)
Organoids in Lung Cancer Management
(
2021
)
Squalene epoxidase induces nonalcoholic steatohepatitis via binding to carbonic anhydrase III and is a therapeutic target
(
2021
)
AMOTL1 enhances YAP1 stability and promotes YAP1-driven gastric oncogenesis
(
2020
)
FGF18-FGFR2 signaling triggers the activation of c-Jun-YAP1 axis to promote carcinogenesis in a subgroup of gastric cancer patients and indicates translational potential
(
2020
)
Frequent Integration of HBV DNA in Genomes of Hepatocellular Carcinoma Cells From Patients With Occult Infections
(
2020
)
Patient-derived tumor organoid predicts drugs response in glioblastoma: A step forward in personalized cancer therapy?
(
2020
)
Aberrant enhancer hypomethylation contributes to hepatic carcinogenesis through global transcriptional reprogramming
(
2019
)
A comparability study of immunohistochemical assays for PD-L1 expression in hepatocellular carcinoma
(
2019
)
APLN promotes hepatocellular carcinoma through activating PI3K/Akt pathway and is a druggable target
(
2019
)
A virome-wide clonal integration analysis platform for discovering cancer viral etiology
(
2019
)
Genomic and Epigenomic Features of Primary and Recurrent Hepatocellular Carcinomas
(
2019
)
Genomic landscape of lymphoepithelioma-like hepatocellular carcinoma
(
2019
)
Long‐Read RNA Sequencing Identifies Alternative Splice Variants in Hepatocellular Carcinoma and Tumor‐Specific Isoforms
(
2019
)
Squalene epoxidase drives NAFLD-induced hepatocellular carcinoma and is a pharmaceutical target
(
2018
)
SRGAP1, a crucial target of miR-340 and miR-124, functions as a potential oncogene in gastric tumorigenesis
(
2018
)
Integrative epigenomic analysis of functional enhancers in liver carcinogenesis
(
2017
)
O-GlcNAc transferase promotes fatty liver-associated liver cancer through inducing palmitic acid and activating endoplasmic reticulum stress
(
2017
)
Early-phase circulating miRNAs predict tumor recurrence and survival of hepatocellular carcinoma patients after liver transplantation
(
2016
)
Nanoscale ChIP-seq Analysis in Primary Hepatocellular Carcinoma Tissues Reveals Tumor-specific Chromatin Deregulation for Oncogene Activation
(
2016
)
Oct4/miR-1246 signaling axis drives Wnt/β-catenin activation in liver cancer stem cells
(
2016
)
Personalized therapy for hepatocellular carcinoma: Where are we now?
(
2016
)
Stratification of Digestive Cancers with Different Pathological Features and Survival Outcomes by MicroRNA Expression
(
2016
)
Yin Yang 1-mediated epigenetic silencing of tumour-suppressive microRNAs activates nuclear factor-κB in hepatocellular carcinoma
(
2016
)
Hepatocellular carcinoma-derived exosomes promote motility of immortalized hepatocyte through transfer of oncogenic proteins and RNAs
(
2015
)
Loss of ATOH8 Increases Stem Cell Features of Hepatocellular Carcinoma Cells
(
2015
)
Loss of ATOH8 Increases Stem Cell Features of Hepatocellular Carcinoma Cells
(
2015
)
Novel recurrently mutated genes and a prognostic mutation signature in colorectal cancer
(
2015
)
Transforming Growth Factor-beta-Induced Long Noncoding RNA Promotes Liver Cancer Metastasis via RNA-RNA Crosstalk
(
2015
)
Wnt/β-Catenin activates MiR-183/96/182 expression in hepatocellular carcinoma that promotes cell invasion
(
2015
)
CompleteFusion: Sensitive and Accurate Screening of Fusion Genes Using High-Throughput Sequencing Data
(
2014
)
Share Link
Last updated on 2024-03-09 at 16:10
Share Link
Your name*
Your email*
Recipient's name*
Recipient's email*
Message
Auxilliary Information
No information will be stored or shared with any third party.
Cancel
Our policy towards the use of cookies
All Clarivate Analytics websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.
Ok to Continue
Cookie Policy
